Risk factors associated with pseudoaldosteronism in patients with chronic hepatitis: A retrospective cohort study.
A. Komatsu; T. Yoshino; T. Suzuki; T. Nakamura; T. Kanai; K. Watanabe
(2019) Basic Clin. Pharmacol. Toxicol. 124: 607-614

Improved in vivo targeting of BCL-2 phenotypic conversion through hollow gold nanoshell delivery.
E. Morgan; J.T. Gamble; M.C. Pearce; D.J. Elson; R.L. Tanguay; S.Kumar Kolluri; N.O. Reich
(2019) Apoptosis (accessible online)

Antiproliferative and Cytotoxic Activity of Xanthohumol and Its Non-Estrogenic Derivatives in Colon and Hepatocellular Carcinoma Cell Lines.
I.E. Logan; C.L. Miranda; M.B. Lowry; C.S. Maier; J.F. Stevens; A.F. Gombart
(2019) Int J Mol Sci 20: (accessible online)

Pages